---
id: synthetic-biology
name: Synthetic Biology
family: technological
tier: active
url: https://futuremap.talin.digital/e/synthetic-biology/
license: CC-BY-NC-4.0
---

# Synthetic Biology

## Maturity
2/5 — Commercial in specific ingredients and materials; broader engineering of organisms remains research-stage. Design accelerating faster than scale-up.

Source: E-143 (NASEM, The Age of AI in the Life Sciences, 23 Apr 2025); WKO Innovation Map (2025–2026)

## What it is
Designing and building biological systems that do not exist in nature — engineered organisms, synthetic chromosomes and designed proteins.

## What it does
It treats biology as a manufacturing platform. Where it works, it substitutes biological production for chemical or extractive production, which changes supply chains rather than efficiency.

## Common misconception
That it is an extension of gene editing. Editing modifies what exists; this builds what does not, and the design, biosecurity and scale-up questions are correspondingly different.

## Steepens
- Food System Transformation (food-system-transformation) — moderate
- Circular Economy and Materials Substitution (circular-economy-and-materials-substitution) — moderate
- Zoonotic and Antimicrobial Resistance Risk (zoonotic-and-antimicrobial-resistance-risk) — moderate
- Critical Mineral and Resource Scarcity (critical-mineral-and-resource-scarcity) — marginal

## What would change its gradient
- Fermentation scale-up capacity, which is a capital-intensive bottleneck
- Biosecurity governance keeping pace with diffusing capability
- Feedstock cost, which determines whether biological production competes
